You are here: Industry Insights > ICMR

News List

ICMR says Covaxin-Covishield combination shows better results expresspharma
August 10, 2021
The Indian Council of Medical Research (ICMR), in its recent study, mentioned that mixing and matching of COVID-19 vaccines, namely Covaxin and Covishield, showed better results.
Mix of Covishield, Covaxin yields better results, finds ICMR Study firstwordpharma
August 09, 2021
A study by ICMR involving 98 people, 18 of whom had inadvertently received Covishield as first dose and Covaxin as the second, showed that combining these two COVID-19 vaccines produced better immunogenicity than two doses of the same vaccine.
Abbott launches Panbio COVID-19 Antigen Self-Test in India expresspharma
July 14, 2021
The self-test features a minimally invasive nasal swab and delivers results in as early as15 minutes with no instrumentation.
ICMR proposes clinical trial along with Oxford University to evaluate COVID-19 therapy expresspharma
July 12, 2021
The trial -- 'India-UK RECOVERY (Randomised Evaluation of COVID-19 therapy)'-- will be a multi-centre, adaptive platform trial on Covid patients, ICMR said.
ICMR study finds pregnant, postpartum women more severely affected during COVID second wave expresspharma
June 18, 2021
Symptomatic cases were significantly higher at 28.7 per cent in the second wave, compared to the first wave when the proportion was 14.2 per cent, ICMR said.
Meril gets ICMR nod for COVID-19 self-test, CoviFind expresspharma
June 11, 2021
The test is priced at ₹250 and will be made available as a single-pack, with additional purchase options including a pack of 3, 5 and 25 tests.
Cipla launches ViraGen, a COVID-19 RT-PCR test expresspharma
May 21, 2021
Cipla announced the commercialisation of a polymerase chain reaction (RT-PCR) test kit ‘ViraGen’ for COVID-19 in India, in partnership with Ubio Biotechnology Systems. ViraGen is Cipla’s third offering in the COVID-19 testing segment.
Plasma therapy not helpful, may get removed from COVID-19 clinical management guidelines expresspharma
May 17, 2021
Plasma therapy on COVID-19 patients has not been found effective in reducing the progression to severe disease or death and is likely to be dropped from the clinical management guidelines, sources said.
Bharat Biotech, ICMR announce interim results from Phase 3 trials of COVAXIN expresspharma
April 22, 2021
Bharat Biotech announced phase 3 interim analysis results of COVAXIN. The second interim analysis is based on accruing more than 87 symptomatic cases of COVID-19. Due to the recent surge in cases, 127 symptomatic cases were recorded, resulting in a ...
Vice President Venkaiah Naidu meets Bharat Biotech CMD, discusses status of Covaxin expresspharma
December 28, 2020
Naidu stressed the importance of PPPs in coming out with indigenous world-class products.

Previous page 1 2 3 4 Next page